Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of ProQR Therapeutics (NASDAQ:PRQR) through any online brokerage.
Other companies in ProQR Therapeutics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
ProQR Therapeutics has a consensus price target of $8.00.
The stock price for ProQR Therapeutics (NASDAQ: PRQR) is $2.34 last updated August 21, 2026 at 7:30 PM EDT.
There are no upcoming dividends for ProQR Therapeutics.
ProQR Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for ProQR Therapeutics.
ProQR Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.